Abstract:Objective-Cellular senescence influences organismal aging and increases predisposition to age-related diseases, in particular cardiovascular disease, a leading cause of death and disability worldwide. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) is a master regulator of mitochondrial biogenesis and function, oxidative stress, and insulin resistance. Senescence is associated with telomere and mitochondrial dysfunction and oxidative stress, implying a potential causal role of PGC-1 alpha in senescence pathogenesis.Approach and Results-We generated a PGC-1 alpha(+/-)/apolipoprotein E-/- mouse model and showed that PGC-1 alpha deficiency promotes a vascular senescence phenotype that is associated with increased oxidative stress, mitochondrial abnormalities, and reduced telomerase activity. PGC-1 alpha disruption results in reduced expression of the longevity-related deacetylase sirtuin 1 (SIRT1) and the antioxidant catalase, and increased expression of the senescence marker p53 in aortas. Further, angiotensin II, a major hormonal inducer of vascular senescence, induces prolonged lysine acetylation of PGC-1 alpha and releases the PGC-1 alpha-FoxO1 complex from the SIRT1 promoter, thus reducing SIRT1 expression. The phosphorylation-defective mutant PGC-1 alpha S570A is not acetylated, is constitutively active for forkhead box O1-dependent SIRT1 transcription, and prevents angiotensin II-induced senescence. Acetylation of PGC-1 alpha by angiotensin II interrupts the PGC-1 alpha-forkhead box O1-SIRT1 feed-forward signaling circuit leading to SIRT1 and catalase downregulation and vascular senescence.Conclusions-PGC-1 alpha is a primary negative regulator of vascular senescence. Moreover, the central role of posttranslational modification of PGC-1 alpha in regulating angiotensin II-induced vascular senescence may inform development of novel therapeutic strategies for mitigating age-associated diseases, such as atherosclerosis. (Arterioscler Thromb Vasc Biol. 2013; 33: 988-998.)

Sirt1 Is Regulated By A Ppar Gamma-Sirt1 Negative Feedback Loop Associated With Senescence

THE Sirt GENE FAMILY AND ITS ROLE IN REGULATION OF CELL LIFESPAN

Regulation of SIRT1 in aging: Roles in mitochondrial function and biogenesis

SIRT1 in Transcription Regulation

SIRT1 is downregulated by autophagy in senescence and ageing

SIRT1 and p53, effect on cancer, senescence and beyond.

SIRT1 and aging related signaling pathways

Sirt1: A Novel Adipocyte and Myocyte Regulatory Factor

Peroxisome Proliferator-Activated Receptor Γ Coactivator-1Α is a Central Negative Regulator of Vascular Senescence.

GW24-e2135 SIRT1 Significantly Influences Old Sourced MSCs Aging and Proliferation

Hnrnp A1 Antagonizes Cellular Senescence and Senescence‐associated Secretory Phenotype Via Regulation of SIRT1 Mrna Stability

Regulation of SIRT1 in Cellular Functions: Role of Polyphenols

Redox Regulation of SIRT1 in Inflammation and Cellular Senescence.

Advances in Sirtuin on the Mechanism of Calorie Restriction on Lifespan*

Negative reciprocal regulation between Sirt1 and Per2 modulates the circadian clock and aging

RSL1D1 modulates cell senescence and proliferation via regulation of PPARγ mRNA stability

SIRT1, resveratrol and aging

The Sirtuin-Associated Human Senescence Program Converges on the Activation of Placenta-Specific Gene PAPPA

Sirt1 Overexpression Antagonizes Cellular Senescence with Activated Erk/S6k1 Signaling in Human Diploid Fibroblasts

SIRT1 Promotes Proliferation and Prevents Senescence Through Targeting LKB1 in Primary Porcine Aortic Endothelial Cells.

SIRT1 in metabolic syndrome: where to target matters.